{"id":"NCT04810962","sponsor":"Formosa Pharmaceuticals, Inc.","briefTitle":"Efficacy and Safety of APP13007 for Treatment of Inflammation and Pain After Cataract Surgery Including a Corneal Endothelial Cell Sub-study","officialTitle":"A Multicenter, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of APP13007 for the Treatment of Inflammation and Pain After Cataract Surgery, Including a Corneal Endothelial Cell Sub-study","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-03-16","primaryCompletion":"2022-07-06","completion":"2022-07-06","firstPosted":"2021-03-23","resultsPosted":"2023-07-07","lastUpdate":"2023-07-25"},"enrollment":370,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Ocular Inflammation and Pain After Cataract Surgery"],"interventions":[{"type":"DRUG","name":"APP13007, 0.05%","otherNames":[]},{"type":"DRUG","name":"Matching Vehicle Placebo for APP13007, 0.05%","otherNames":[]}],"arms":[{"label":"APP13007 0.05% BID","type":"EXPERIMENTAL"},{"label":"Matching Vehicle Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This Phase 3 study will evaluate APP13007 in comparison to the matching vehicle placebo in a randomized, parallel-group, double-masked fashion. The subjects will have undergone routine cataract surgery on Day 0 of the study and will be assessed the next day (Post-operative Day; POD1) after uncomplicated surgery for eligibility for randomization to study treatment. The study comprises the Main Study and the Endothelial Cell Sub-study.","primaryOutcome":{"measure":"Participants With ACC Count = 0 in the Operated Study Eye at All Visits From Postoperative Day 8 Through Postoperative Day 15 Without Rescue Medication","timeFrame":"Postoperative Day 8 and Postoperative Day 15","effectByArm":[{"arm":"APP13007 0.05% BID","deltaMin":49,"sd":null},{"arm":"Matching Vehicle Placebo","deltaMin":16,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":3},"locations":{"siteCount":31,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":184},"commonTop":["Eye inflammation"]}}